Smaller melanoma skin cancer cells may be more vulnerable to drugs that block DNA repair, while larger cells might be more responsive to immunotherapy.
Certain skin cancer cells may differ in how they respond to various treatments according to their size. Better understanding this and how it relates to treatment outcomes could help doctors predict an individual’s drug response.
Continued Article: https://www.newscientist.com/article/2356508-the-size-of-skin-cancer-cells-may-affect-how-they-respond-to-treatment/
